Karen M. Dahut - 20 May 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Karen M Dahut
Issuer symbol
DXCM
Transactions as of
20 May 2022
Net transactions value
+$0.987
Form type
4
Filing time
23 May 2022, 17:04:42 UTC
Previous filing
23 May 2022
Next filing
27 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Other $0 -387 -19% $0.000000 1,691 11 Aug 2021 Direct F1
transaction DXCM Common Stock Other $0 -918 -54% $0.000000 773 19 May 2022 Direct F1
transaction DXCM Common Stock Award $0.987 +987 +128% $0.001000* 1,760 20 May 2022 Direct F2, F3
transaction DXCM Common Stock Other $0 +387 $0.000000 387 11 Aug 2021 by Trust F1, F4
transaction DXCM Common Stock Other $0 +918 +237% $0.000000 1,305 19 May 2022 by Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred from direct ownership to ownership under the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, upon vesting of previously awarded restricted stock units.
F2 The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F3 Included in this number are 1,760 unvested restricted stock units, 987 of which were granted on May 20, 2022 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2023 Annual Meeting and 773 of which were granted on August 11, 2020 and shall vest through August 11, 2023.
F4 Shares are held by the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, with respect to which the reporting person is a trustee.